Phase II Sunitinib Prog Met AIPC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Connecticut Oncology & Hematology, Llp
Torrington, Connecticut, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Cancer Care & Hematology Specialista of Chicagoland
Niles, Illinois, United States
- Hope Center
Terre Haute, Indiana, United States
- Maryland Oncology Hematology, P.A.
Columbia, Maryland, United States
- Alliance Hematology Oncology Pa
Westminster, Maryland, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- St. Joseph Oncology, Inc.
Saint Joseph, Missouri, United States
- Arch Medical Services, Inc. Dba the Cntr for Cancer Care & Research
St Louis, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Nh Oncology-Hematology Pa
Hooksett, New Hampshire, United States
- New Mexico Cancer Care Associates
Santa Fe, New Mexico, United States
- New York Oncology Hematology, P.C.
Albany, New York, United States
- Interlakes Oncology Hematology, Pc
Rochester, New York, United States
- Cancer Centers of North Carolina
Raleigh, North Carolina, United States
- Greater Dayton Cancer Center
Kettering, Ohio, United States
- Medical Oncology Associates
Kingston, Pennsylvania, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Texas Cancer Center-Abilene(south)
Abilene, Texas, United States
- Texas Oncology, P.A.-Amarillo
Amarillo, Texas, United States
- Texas Cancer Center
Arlington, Texas, United States
- Texas Oncology Cancer Center
Austin, Texas, United States
- Mamie Mcfaddin Ward Cancer Center
Beaumont, Texas, United States
- Texas Oncology, P.A.-Bedford
Bedford, Texas, United States
- Methodist Charlton Cancer Ctr.
Dallas, Texas, United States
- Texas Cancer Center at Medical City
Dallas, Texas, United States
- Texas Onclogy, P.A.
Dallas, Texas, United States
- Texas Oncology, P.A.
Dallas, Texas, United States
- Texas Cancer Center
Denton, Texas, United States
- El Paso Cancer Treatment Ctr
El Paso, Texas, United States
- Texas Oncology, P.A.
Fort Worth, Texas, United States
- Allison Cancer Center
Midland, Texas, United States
- Texas Oncology-Odessa
Odessa, Texas, United States
- Paris Regional Cancer Center
Paris, Texas, United States
- Hoast-Medical Dr.
San Antonio, Texas, United States
- Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas, United States
- Texas Oncology Cancer Care and Research
Waco, Texas, United States
- Texas Oncology, P.A.
Webster, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2007
- Primary completion
- 30 Jun 2009
- Completion
- 30 Jun 2009
- Last update posted
- 25 Oct 2018
- Registered enrollment
- 36
- Registry id
- NCT00599313
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.